Akari Therapeutics Plc (AKTX)

0.2657 0.00 (0.00%) USD  |  NASDAQ  |  Dec 26, 16:00
0.273 +0.01 (+2.75%) After-Hours: 20:00
More

Akari Therapeutics Amortization Expense CF (% of Quarterly Assets)

Amortization Expense CF (% of Quarterly Assets) Chart

View Amortization Expense CF (% of Quarterly Assets) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years

View Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (% of Quarterly Assets) Benchmarks

View Amortization Expense CF (% of Quarterly Assets) Benchmarks
Start Trial
DBV Technologies SA --
Ascendis Pharma A/S Upgrade
Cellectis SA --
Biodexa Pharmaceuticals Plc --
NuCana Plc --